Hermetica Superfood Encyclopedia
The Short Answer
Hericium coralloides produces unique meroterpenoids called corallocins A, B, and C, which promote nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) expression in neural tissue, offering a mechanistic basis for neuroprotective activity. Preclinical isolation studies identified corallocin A inducing strong NGF protein expression and hippocampal neuron survival in culture, while corallocins B and C upregulated BDNF, though no human clinical trials have yet quantified these effects in vivo.
CategoryMushroom
GroupMushroom/Fungi
Evidence LevelPreliminary
Primary KeywordHericium coralloides benefits
Coral Tooth Mushroom — botanical close-up
Health Benefits
**Neuroprotection via Neurotrophic Factor Induction**
Corallocin A isolated from fruiting bodies elicits strong NGF protein expression in C6 glioma cells and promotes survival responses in cultured hippocampal neurons, suggesting potential for supporting neural integrity and resilience against neurodegenerative stressors.
**BDNF Upregulation for Cognitive Support**
Corallocins B and C have demonstrated the ability to upregulate BDNF expression in preclinical cell models, a neurotrophin critical for synaptic plasticity, long-term potentiation, and maintenance of learning and memory circuits.
**Antimicrobial Activity**: Culture fluid extracts from H
coralloides exhibit broad-spectrum antimicrobial properties, with the strongest effect recorded at 21 days of fungal growth producing a 32.1 cm growth inhibition zone, suggesting bioactive secondary metabolites with antibiotic potential.
**Antioxidant Activity via Polysaccharides and Phenolics**
Like related Hericium species, H. coralloides contains polysaccharides (155–177 mg per 100 g dry weight in fruiting bodies) and phenolic compounds that contribute to free radical scavenging activity, potentially reducing oxidative stress in tissues.
**Immunomodulatory Potential**
Beta-glucan-rich polysaccharides present in the fruiting body and mycelium of H. coralloides are structurally analogous to immunomodulatory compounds characterized in H. erinaceus, suggesting potential for modulating innate immune responses via pattern recognition receptor engagement, though direct evidence for this species remains limited.
**Gastrointestinal Mucosal Support**
Extrapolating from the broader Hericium genus, polysaccharide fractions may support gastric mucosal integrity and gut microbiota balance, an effect demonstrated in H. erinaceus models; species-specific evidence for H. coralloides requires direct study.
Origin & History
Natural habitat
Hericium coralloides is a saprophytic and parasitic fungus native to temperate forests across North America, Europe, and Asia, where it grows on the dead or dying wood of hardwood trees such as oak, beech, and maple. It is distinguished from its close relative H. erinaceus by its branching, coral-like fruiting body structure with clusters of fine downward-pointing spines. The species thrives in late summer through autumn in moist, shaded forest environments and is less commonly cultivated than H. erinaceus, though it can be grown on hardwood substrate logs or supplemented sawdust blocks under controlled humidity conditions.
“Hericium coralloides has been recognized as an edible and medicinally interesting fungus in European and East Asian folk traditions, where it was collected from forest hardwoods and consumed as a food or prepared as a decoction alongside other medicinal fungi, though it was less prominently featured in classical Chinese materia medica compared to H. erinaceus (known as 'Hou Tou Gu' or monkey head mushroom). In European ethnomycology, coral tooth fungi were foraged seasonally and valued primarily as a culinary delicacy with tonic properties, though detailed pharmacological documentation in historical texts is sparse relative to better-studied medicinal fungi. Indigenous foraging communities in North America recognized the species as edible, and it was occasionally used in folk preparations intended to support digestion and general vitality, following broad patterns common to many saprophytic forest fungi. Modern scientific interest in H. coralloides as a distinct medicinal species has accelerated only in the past two decades with the isolation and characterization of species-specific corallocin compounds, repositioning it from a culinary curiosity to a candidate neuroprotective ingredient.”Traditional Medicine
Scientific Research
The evidence base for Hericium coralloides as a medicinal ingredient is at an early preclinical stage, consisting primarily of in vitro compound isolation studies and antimicrobial assays, with no published human clinical trials identified as of the current literature review. The landmark corallocin isolation study extracted corallocins A, B, and C from 7.88 g of ethyl acetate crude extract from fruiting bodies, demonstrating NGF and BDNF induction in C6 glioma cells and hippocampal neurons in culture, but these are cell-based findings that require validation in animal models and ultimately human trials. Antimicrobial activity has been characterized through agar diffusion assays measuring growth inhibition zones, which represent functional but non-mechanistic evidence requiring further structural and pharmacokinetic elucidation. The broader Hericium genus, particularly H. erinaceus, benefits from a substantially larger evidence base including rodent neuroprotection models and small human RCTs, and while species relatedness suggests translational potential, direct extrapolation to H. coralloides cannot be made without species-specific data.
Preparation & Dosage
Traditional preparation
**Whole Dried Fruiting Body Powder**
2–5 g per serving; research-grade preparations have used standardized extracts rather than whole powder
No clinically validated dose established; culinary use typically involves
**Hot Water Extract (Beta-Glucan Standardized)**
155–177 mg per 100 g dry weight in fruiting bodies suggest relatively modest extraction yields; no standardized supplement dose established for H
Polysaccharide yields of . coralloides specifically
**Ethyl Acetate / Organic Solvent Extract**
Used in isolation studies to concentrate corallocin meroterpenoids; not currently standardized for commercial supplementation
**Mycelium-Based Preparations**
6 mg/100 g dry weight for select bioactives; biomass fermentation is used in some commercial Hericium genus products, though H
Mycelium of H. coralloides has shown compound concentrations up to 21.. coralloides mycelium products are uncommon
**Traditional Preparation (Culinary)**
Consumed cooked in East Asian and European traditions; boiling or sautéing in water or fat extracts both water-soluble polysaccharides and some lipophilic terpenoids
**Dosage Note**
500–3000 mg extract daily) as a provisional analog, but this is not evidence-based for this species
In the absence of H. coralloides-specific human trial data, no safe or effective dose range can be formally recommended; practitioners often reference H. erinaceus dosing (
Nutritional Profile
Hericium coralloides fruiting bodies contain polysaccharides at concentrations of 155–177 mg per 100 g dry weight, with beta-glucans representing the primary immunoactive fraction. Protein content is moderate, typical of Hericium genus fungi at approximately 20–30% of dry weight, providing a range of essential amino acids including lysine and threonine. Phenolic compounds and terpenoids, including the species-specific meroterpenoids corallocin A (2.8 mg), B (29.4 mg), and C (3.4 mg) per standardized extraction batch from 7.88 g crude extract, constitute the key secondary metabolite profile. Dietary fiber (primarily chitin and beta-glucans), trace minerals including potassium, phosphorus, and zinc, and B-vitamins (riboflavin, niacin) are present in amounts consistent with related edible fungi, though species-specific quantitative nutritional analysis remains incompletely published; bioavailability of terpenoid compounds is likely enhanced by lipid co-ingestion given their hydrophobic character.
How It Works
Mechanism of Action
Corallocin A, a benzofuranone-type meroterpenoid, stimulates NGF protein expression in glial and neuronal cell lines, with downstream signaling through the TrkA receptor pathway promoting neuronal differentiation, axonal outgrowth, and hippocampal neuron survival in culture. Corallocins B and C, structurally related isoindolinone-type meroterpenoids, upregulate BDNF expression, engaging TrkB signaling cascades associated with synaptic plasticity and neuroprotection against excitotoxic and oxidative insults. The polysaccharide fraction, composed primarily of beta-(1,3)/(1,6)-glucans, is believed to interact with Dectin-1 and Toll-like receptor 2 on innate immune cells, triggering NF-κB-mediated cytokine modulation and enhancing macrophage activation. Phenolic constituents contribute additional antioxidant activity through direct radical scavenging and potential modulation of Nrf2/HO-1 pathways, though these mechanisms have not been explicitly characterized for H. coralloides in published literature.
Clinical Evidence
No clinical trials specific to Hericium coralloides supplementation in humans have been published or identified in available literature. The existing evidence is limited to in vitro studies demonstrating neurotrophic factor induction by corallocin compounds and antimicrobial assays quantifying culture fluid bioactivity. Outcomes such as cognitive performance, neurological function, immune modulation, or gastrointestinal health have not been measured in human subjects for this species. Confidence in clinical benefit is therefore very low and speculative at this stage; researchers and formulators should distinguish H. coralloides from H. erinaceus when assessing evidence-based applications, as the clinical trial literature of the latter cannot be directly attributed to the former.
Safety & Interactions
No formal toxicological studies or safety trials have been conducted specifically for Hericium coralloides in humans, and adverse effect data is therefore unavailable for this species; safety inferences are currently extrapolated cautiously from H. erinaceus research, where a NOAEL of 2000 mg/kg body weight per day was established in animal studies for standardized mycelium extracts. Individuals with known hypersensitivity to fungi or mold should exercise caution, as allergic reactions including contact dermatitis and respiratory sensitivity have been reported with Hericium genus mushrooms in sensitized individuals. No specific drug interaction data exists for H. coralloides; however, theoretical interactions with anticoagulants (due to platelet-modulating polysaccharides), immunosuppressants (due to immunostimulatory beta-glucans), and hypoglycemic agents cannot be excluded based on class-level pharmacology of related fungal species. Pregnant and lactating individuals should avoid supplemental forms of H. coralloides until dedicated safety data is available, though culinary consumption of cooked fruiting bodies is unlikely to pose significant risk at typical dietary quantities.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Hericium coralloides (Scop.) Pers.Coral Hedgehog MushroomComb Tooth FungusHericium ramosumCoral Tooth Fungus
Frequently Asked Questions
What are corallocins and what do they do?
Corallocins A, B, and C are species-specific meroterpenoid compounds isolated from the fruiting bodies of Hericium coralloides. Corallocin A stimulates NGF protein expression in glial cells and promotes hippocampal neuron survival in culture, while corallocins B and C upregulate BDNF expression, both of which are neurotrophins essential for neuronal maintenance and synaptic plasticity. These compounds were isolated at yields of 2.8 mg, 29.4 mg, and 3.4 mg respectively from a standardized ethyl acetate extraction, and represent the most pharmacologically characterized bioactives unique to this species.
Is Hericium coralloides the same as Lion's Mane mushroom?
Hericium coralloides is a distinct species from Hericium erinaceus (Lion's Mane), though they belong to the same genus and share some bioactive compound classes including polysaccharides and terpenoids. H. erinaceus has a single, undivided, pom-pom-like fruiting body, while H. coralloides has a branching, coral-like structure with clusters of fine spines. Importantly, H. coralloides produces unique corallocin compounds not found in H. erinaceus, and its clinical evidence base is far more limited, so the two species should not be used interchangeably in medicinal contexts.
What is the recommended dose of Hericium coralloides supplements?
No clinically validated or regulatory-approved dose has been established for Hericium coralloides, as no human clinical trials have been completed for this species. Some formulators provisionally reference H. erinaceus dosing ranges of 500–3000 mg of standardized extract daily as an analog, but this extrapolation is not evidence-based for H. coralloides specifically. Until species-specific pharmacokinetic and efficacy data are available, any supplementation should be approached conservatively and under guidance of a qualified healthcare provider.
Is Hericium coralloides safe to consume?
Hericium coralloides has a long history of safe culinary use as a cooked edible mushroom in European and East Asian foraging traditions, and no serious adverse events have been documented from food consumption. However, no formal human safety or toxicology trials have been conducted for supplemental or concentrated extract forms of H. coralloides, meaning the safety profile at therapeutic doses is not established. Individuals with fungal allergies, those on immunosuppressant or anticoagulant therapy, and pregnant or lactating individuals should exercise particular caution and consult a healthcare professional before use.
Does Hericium coralloides have antimicrobial properties?
Yes, preclinical research has demonstrated antimicrobial activity in Hericium coralloides culture fluid, with the strongest inhibitory effect observed at day 21 of fungal growth, producing a growth inhibition zone of 32.1 cm in agar diffusion assays. The specific antimicrobial compounds responsible have not been fully characterized, but secondary metabolites including terpenoids and phenolic compounds are likely contributors based on analogous findings in related fungal species. This antimicrobial activity remains at the in vitro research stage and has not been validated in animal models or human subjects.
What does clinical research show about Hericium coralloides and brain health?
Research demonstrates that corallocin compounds from Hericium coralloides stimulate nerve growth factor (NGF) production in brain cells, which supports neuronal survival and protection against degeneration. Studies on cultured hippocampal neurons show the mushroom promotes resilience against neurodegenerative stressors, suggesting potential cognitive support benefits. However, most evidence remains in cellular and animal models, with limited human clinical trials currently available.
How does Hericium coralloides support cognitive function compared to other mushroom species?
While both Hericium coralloides and Lion's Mane contain neuroactive compounds, coralloides is specifically rich in corallocins A, B, and C, which show strong NGF and BDNF upregulation in research. This targeted neurotropic activity makes it particularly valued for supporting neural integrity and cognitive resilience. Each Hericium species has distinct bioactive profiles, so they may offer complementary rather than identical benefits.
Who benefits most from taking Hericium coralloides supplements?
Hericium coralloides may be most beneficial for individuals concerned with cognitive health, memory support, and neurological resilience due to its NGF and BDNF-promoting properties. Those experiencing age-related cognitive changes or seeking proactive neuroprotection are common users of this supplement. It may also appeal to people supporting overall brain health and mental clarity as part of a comprehensive wellness routine.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w coral-tooth-mushroom-hericium-coralloides curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
